For long term oriented dividend growth investors in the accumulation phase, bull markets really are a double edged sword. On one side, it’s great to see the book values of share positions grow and of course this is a significant factor in the wealth accumulation process. On the other side, acquiring income generating assets is tough when they get more and more expensive.

September 2021 showed some welcome price pressure on international stock markets and after a few days of red stock market days, I decided to pull the trigger and put the amount of roughly Swiss francs 8’000 (CHF; 1 CHF = USD 1.1) to work by investing into following businesses (see in brackets the invested amounts):

• Geberit (CHF 1’377)
• Schindler (CHF 1’928)
• Emmi (CHF 1’960)
• Ems Chemie (CHF 1’783)
• Eckert & Ziegler (CHF 953)

Geberit is a Swiss multinational group which is specialized in manufacturing and supplying sanitary parts and related systems. Geberit has an incredible economic moat on the back of a strong brand giving the company with pricing power. I particularily like the very strong financials with very low debts (debt-equity ratio of around 0.40).

Schindler is another Swiss “hidden stock gem” with an amazing international presence. The group manufactures escalators, moving walkways and elevators around the world. The business model is attractive with high ROI and benefitting of global megatrends (population growth). Like its peers Otis, Kone and Thyssen, we see as well with Schindler an attractive element: recurring income as escalators and elevators need regular services once they are installed.

Emmi is a Swiss milk processor and dairy products business. It’s a rather small company compared for instance with Danone, but I know that company quite well which operates in my home-market Switzerland.

With already some chemical business exposure through investments in BASF, Covestro, Victrex etc., I hesitated some time buying stocks of Swiss specialty chemical player Ems Chemie. But as we have here such a high quality business and with the stock price having been falling so nicely in September, I just couldn’t pass on this buying opportunity.

Eckert & Ziegler has been on my personal watchlist for some time. The company is one of the world’s largest providers of isotope technology for medical, scientific and industrial use. The core businesses of the group are cancer therapy, industrial radiometry and nuclear-medical imaging.

For 2021, I target USD 15’000 in total passive income and these five new stock holding positions having been added in October will strengthen my Dividend Portfolio further and increase my forward dividend income by around USD 200.

It’s just great getting paid each month with dividends and giving my income a nice boost.

What about you, fellow reader, did you buy some stocks recently?

Disclaimer

You are responsible for your own investment and financial decisions. This article is not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action.